Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.73M | -2.30M | -1.72M | -1.88M | -1.30M |
| Total Depreciation and Amortization | 15.30K | 11.40K | 6.40K | 6.60K | 6.60K |
| Total Amortization of Deferred Charges | 73.20K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.08M | 307.70K | 189.50K | 1.29M | 802.30K |
| Change in Net Operating Assets | -3.20M | 181.20K | -13.40K | 150.10K | -84.20K |
| Cash from Operations | -6.76M | -1.80M | -1.54M | -431.60K | -573.80K |
| Capital Expenditure | -41.40K | -30.10K | -4.70K | 0.00 | -400.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -- | -30.90K | -40.40K |
| Cash from Investing | -41.40K | -30.10K | -4.70K | -30.90K | -40.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -92.20K | -- | -- | 0.00 | 3.90K |
| Issuance of Common Stock | 1.30K | 1.94M | 3.01M | 4.41M | 1.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.80M | 488.80K | 410.30K | 57.50K | -99.60K |
| Cash from Financing | 1.71M | 2.43M | 3.42M | 4.46M | 1.37M |
| Foreign Exchange rate Adjustments | 3.00K | -- | -- | 500.00 | -4.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.09M | 592.90K | 1.88M | 4.00M | 753.70K |